Feature | June 10, 2007 | Cristen C. Bolan

A Fair Playing Field in Digital Mammography?

In a recent letter to the editor, an ITN reader brought up the decision made on May 23rd, 2006, to re-classify digital mammography from a Class III product to Class II. According to the reader, “This was widely thought to mean that the complicated and lengthy process of filing a PMA to gain FDA approval to market digital mammography would no longer be required.”
It was thought that the benefits of the proposed re-classification would enable a much simpler 510(k) application to FDA to be used to gain clearance to market digital mammography. In the meeting, Robert Jennings, M.D., of the FDA said: “The big difference which we feel goes a long way towards our goal of least burdensome approach to device clearance is that we will use, instead of a large clinical trial, simply reader evaluation of clinical films as is done in the ACR accreditation process.”
This would allow manufacturers entering the market to avoid the lengthy clinical study required in the PMA process. The new approach would also benefit patient care by not double exposing participants.
Although it was unanimously recommended that the FDA should develop the guidance documents required to reclassify digital mammography to a 510(k), nine months later, the FDA stated that it would take at least an additional one and a half to two years for the FDA to complete the guidance documents describing the requirements for a digital mammography 510(k). They added that the ultimate requirements would include a large clinical trial similar to that required for a PMA, including double exposure of participating patients and a one-year follow-up of negative diagnoses.
Why did the reader bring this to my attention? In hopes that other industry experts would join in on requesting that the FDA complete “the guidance documents for digital mammography 510(k) within the next six months” and “eliminate the need for a large clinical trial for a digital mammography 510(k).” This way, our reader believes, other qualified manufacturers would not be left sitting on the sidelines, while just a few players “divide up the large and growing digital mammography market.”
It begs the question – has the FDA established a fair playing field for all qualified manufacturers or does the market cater to a few powerhouses to lead the medical imaging market? That’s for you to decide. I just hope, above all, it’s catering to the patients.

We welcome your comments on the topics found in Imaging Technology News.
Please send your thoughts to [email protected]
Please send press releases to [email protected]
and chart responses to [email protected]

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Women Prefer Getting Mammograms Every Year
News | Mammography | January 09, 2018
Women prefer to get their mammograms every year, instead of every two years, according to a new study presented at the...
Planmed Clarity 2-D Digital Mammography System Receives FDA Approval
Technology | Mammography | January 08, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the Planmed Clarity 2-D full-field digital...
Overweight Women May Need More Frequent Mammograms
News | Mammography | January 04, 2018
Women with higher body mass index (BMI) face an increased risk of not detecting their breast tumor until it has become...
About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

Feature | Breast Imaging | January 02, 2018 | Kathryn Pearson Peyton, M.D.
Sixty million women undergo regular screening mammography in the United States, but even in the digital age, it is di
Double Black Announces Gemini Series Monitors for Multimodality and Digital Breast Imaging
Technology | Flat Panel Displays | December 28, 2017
December 28, 2017 — Double Black Imaging and their Image Systems Division are releasing their Gemini Series 6MP and 8
iCAD's PowerLook Tomo Detection Experiences Growing Adoption
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Siemens Healthineers Introduces Mammomat Revelation Mammography System for Improved Biopsy Workflow
Technology | Mammography | December 11, 2017
Siemens Healthineers unveiled the new Mammomat Revelation premium mammography platform at the 2017 Radiological Society...
Breast Cancer Screening Performance Impacted by Mean Mammographic Compression Pressure
News | Mammography | December 08, 2017
Dutch researchers demonstrated a strong relationship between compression pressure in mammography and breast cancer...
Videos | Mammography | December 06, 2017
Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre,
Overlay Init